Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.392\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1ccccc1NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1
b. O=C(Cn1cc(S(=O)(=O)Cc2ccc([N+](=O)[O-])cc2)c2ccccc21)N1CCOCC1
Answer: a. Cc1ccccc1NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1
Cc1ccccc1NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1
N-(2-methylphenyl)-3-morpholin-4-ylsulfonylbenzamide